Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Dissecting signaling parameters in autoreactive B cells

View through CrossRef
Abstract In systemic lupus erythematosus (SLE), IgG antibodies (Abs) directed against nuclear antigens (ANA) are pathogenic. Healthy individuals (HC) harbor a similar frequency of ANA+ mature B cells without producing pathogenic IgG Abs. Differences in behavior between ANA+/- B cells in SLE patients and HC have not been explored. The aim of this study was to measure the response to BCR activation in the ANA+/- B cell subpopulations in SLE patients and HC. B cells from 7 SLE patients and 5 HC were isolated and activated with F(ab)'2 fragments of anti-IgG Abs. Calcium flux was measured using indo-1 AM. The response was quantified by area under the curve (AUC), using the bound/unbound ratio of the marker for 5 minutes after activation. Values were compared using Wilcoxon rank sum test. In SLE patients, ANA+ IgG memory cells have a stronger calcium influx than ANA- (AUC for ANA + vs -: 89.46±18.51 vs 76.17±12.65; p=0.05). This difference is not present in HC (AUC for ANA + vs -: 88.02±16.51 vs 89.52±14.49; p=ns). In both HC and SLE patients, ANA+ naïve B cells are less responsive to BCR activation, suggesting anergy. IgM+ B cells overall, irrespective of ANA status, seem to be less responsive in patients with SLE. These results show that ANA+ IgG memory B cells are hyperreactive in SLE patients. The data also suggests a mechanism for the breach in tolerance that is observed in SLE. Further studies are warranted to explore the mechanism and effects on autoantibody generation in SLE.
Title: Dissecting signaling parameters in autoreactive B cells
Description:
Abstract In systemic lupus erythematosus (SLE), IgG antibodies (Abs) directed against nuclear antigens (ANA) are pathogenic.
Healthy individuals (HC) harbor a similar frequency of ANA+ mature B cells without producing pathogenic IgG Abs.
Differences in behavior between ANA+/- B cells in SLE patients and HC have not been explored.
The aim of this study was to measure the response to BCR activation in the ANA+/- B cell subpopulations in SLE patients and HC.
B cells from 7 SLE patients and 5 HC were isolated and activated with F(ab)'2 fragments of anti-IgG Abs.
Calcium flux was measured using indo-1 AM.
The response was quantified by area under the curve (AUC), using the bound/unbound ratio of the marker for 5 minutes after activation.
Values were compared using Wilcoxon rank sum test.
In SLE patients, ANA+ IgG memory cells have a stronger calcium influx than ANA- (AUC for ANA + vs -: 89.
46±18.
51 vs 76.
17±12.
65; p=0.
05).
This difference is not present in HC (AUC for ANA + vs -: 88.
02±16.
51 vs 89.
52±14.
49; p=ns).
In both HC and SLE patients, ANA+ naïve B cells are less responsive to BCR activation, suggesting anergy.
IgM+ B cells overall, irrespective of ANA status, seem to be less responsive in patients with SLE.
These results show that ANA+ IgG memory B cells are hyperreactive in SLE patients.
The data also suggests a mechanism for the breach in tolerance that is observed in SLE.
Further studies are warranted to explore the mechanism and effects on autoantibody generation in SLE.

Related Results

Autoimmunity Checkpoints As Therapeutic Targets in B-Cell Malignancies
Autoimmunity Checkpoints As Therapeutic Targets in B-Cell Malignancies
Abstract Concept. Targeted therapy of cancer typically focuses on inhibitors (e.g. tyrosine kinase inhibitors) that suppress oncogenic signaling below a minimum thre...
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
Human tissues comprise trillions of cells that populate a complex space of molecular phenotypes and functions and that vary in abundance by 4–9 orders of magnitude. Relying solely ...
Abstract 1777: A non-signaling CAR for gamma-delta (γδ) T cells to preserve healthy tissues
Abstract 1777: A non-signaling CAR for gamma-delta (γδ) T cells to preserve healthy tissues
Abstract Chimeric antigen receptor T cell (CAR-T) therapy for B cell leukemias and lymphomas have shown remarkable responses in the clinic. However, the elimination ...
Stem cells
Stem cells
What is a stem cell? The term is a combination of ‘cell’ and ‘stem’. A cell is a major category of living thing, while a stem is a site of growth and support for something else. In...
Megakaryocytes Support Viability Proliferation and Protection of Primary Pre-B ALL Cells from Chemotherapy
Megakaryocytes Support Viability Proliferation and Protection of Primary Pre-B ALL Cells from Chemotherapy
Abstract BACKGROUND: The bone marrow is known to shelter leukemia cells from chemotherapy and contributes to the survival of chemotherapy resistant residual cells, t...
p62 Signaling Is Increased in Multiple Myeloma Microenvironment.
p62 Signaling Is Increased in Multiple Myeloma Microenvironment.
Abstract The bone microenvironment plays a critical role in promoting both tumor growth and bone destruction in myeloma (MM). Marrow stromal cells produce factors, w...
Abstract 1427: IL6 trans-signaling robustly promotes the expansion and antitumor activity of CAR T cells
Abstract 1427: IL6 trans-signaling robustly promotes the expansion and antitumor activity of CAR T cells
Abstract Chimeric antigen receptor T (CAR T) cell immunotherapy targeting CD19 positive B cells malignancies induces promising clinical remissions. However, the trea...
Kras Plays An Important Role In Generating Differentiated Blood Cells
Kras Plays An Important Role In Generating Differentiated Blood Cells
Abstract Background Kras is a small GTPase essential for mouse embryonic development. Although Kras-/- fetal liver cells reconst...

Back to Top